Chemoinformaics analysis of Stigmastan-3,5-diene
| Molecular Weight | 396.703 | nRot | 6 |
| Heavy Atom Molecular Weight | 348.319 | nRig | 20 |
| Exact Molecular Weight | 396.376 | nRing | 4 |
| Solubility: LogS | -7.42 | nHRing | 0 |
| Solubility: LogP | 8.305 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 80.4361 |
| nHD | 0 | BPOL | 48.1539 |
| QED | 0.42 |
| Synth | 4.507 |
| Natural Product Likeliness | 2.786 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.925 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.924 |
| MDCK | 0.00000481 |
| BBB | 0.487 |
| PPB | 0.992408 |
| VDSS | 3.252 |
| FU | 0.0126501 |
| CYP1A2-inh | 0.056 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.106 |
| CYP2c19-sub | 0.973 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.478 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.88 |
| CYP3a4-inh | 0.344 |
| CYP3a4-sub | 0.864 |
| CL | 13.914 |
| T12 | 0.017 |
| hERG | 0.978 |
| Ames | 0.012 |
| ROA | 0.049 |
| SkinSen | 0.975 |
| Carcinogencity | 0.032 |
| EI | 0.013 |
| Respiratory | 0.726 |
| NR-Aromatase | 0.047 |
| Antiviral | No |
| Prediction | 0.706737 |